To: Tamara Syrek Jensen Director, Coverage and Analysis Group, Centers for Medicare and Medicaid Services
"Our organizations support the adoption of appropriate Medicare coverage of therapeutic CGM systems for patients with diabetes, as indicated in our respective clinical practice guidelines and recommendations. Each organization developed these guidelines and recommendations through analysis of published scientific and clinical evidence, as well as the input and advice of our members. This evidence has repeatedly demonstrated that CGM systems can help certain patients improve their glucose control by providing actionable data to adjust insulin to keep blood sugar in range."
Read the Full Letter
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your US representatives or European Members of Parliament through our online platform. Take action and make a difference today.
